Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a versioning update rather than a modification to study content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.2 was applied; there are no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1; this is a minor maintenance update that does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedKyntra Bio is now listed as sponsor, and FibroGen is no longer listed as sponsor.SummaryDifference0.2%

- Check87 days agoChange DetectedThe page shows a minor revision from v3.3.3 to v3.3.4 with no observable changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.